Results 201 to 210 of about 42,305 (336)

Engineering Botulinum Toxins to Improve and Expand Targeting and SNARE Cleavage Activity. [PDF]

Toxins (Basel), 2018
Fonfria E, Elliott M, Beard M, Chaddock JA, Krupp J.   +4 more
europepmc   +1 more source

A guide to the types, structures, and multifaceted functions of matrix metalloproteinases in cancer

The FEBS Journal, EarlyView.
Matrix metalloproteinases (MMPs) orchestrate cancer progression and metastasis through proteolytic and non‐proteolytic actions. By remodeling the tumor microenvironment, enhancing growth factor availability, and modulating cell behavior, MMPs promote proliferation, migration or invasion, and epithelial‐to‐mesenchymal transition. Alongside extracellular
Zoi Piperigkou, Sylvia Mangani, Spyros Kremmydas, Nikolaos E. Koletsis, Nikos K. Karamanos   +4 more
wiley   +1 more source

Botulinum toxins in clinical practice: Gaps in knowledge. [PDF]

Neurol Clin Pract, 2016
Barbano RL.
europepmc   +1 more source

Understanding Clinical Effectiveness and Safety Implications of Botulinum Toxin in Children: A Narrative Review of the Literature

Salvatore Crisafulli, Francesco Ciccimarra, Zakir Khan, Francesco Maccarrone, Gianluca Trifirò   +4 more
openalex   +1 more source

Therapeutic Effect of Botulinum Toxin A on Sensory Bladder Disorders—From Bench to Bedside [PDF]

, 2020
Yuan‐Hong Jiang, Wan‐Ru Yu, Hann‐Chorng Kuo   +2 more
openalex   +1 more source

A multicenter, prospective, single‐arm study of 60‐day peripheral nerve stimulation of the occipital nerves for the treatment of headache

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective The aim of this study was to evaluate the efficacy and safety of a 60‐day peripheral nerve stimulation (PNS) treatment targeting the occipital nerves for reducing pain and improving function in individuals diagnosed with cervicogenic headache or occipital neuralgia. Background Headache conditions are prevalent and commonly disabling,
Genaro G. Gutierrez, Zachary L. McCormick, Mitchell P. Engle, Christopher A. Gilmore, Matthew J. Pingree, Jason E. Pope, David J. DiBenedetto, Narayan R. Kissoon, Puneet K. Sayal, Claire A. Zurn, Nathan D. Crosby, Joseph W. Boggs   +11 more
wiley   +1 more source

The action of proteolytic enzymes on Clostridium botulinum type A toxin [PDF]

, 1954
G. Halliwell
openalex   +1 more source

Treatment effectiveness of galcanezumab versus traditional oral migraine preventive medications at 3 months: Results from the TRIUMPH study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective This study assesses the 3‐month effectiveness of the calcitonin gene‐related peptide monoclonal antibody galcanezumab versus traditional oral migraine preventive medications. Background Studies comparing the effectiveness of calcitonin gene‐related peptide monoclonal antibodies versus traditional oral migraine preventive medications ...
Richard B. Lipton, Miguel J. A. Láinez, Zubair Ahmed, Carlos Vallarino, Diego Novick, Maurice Vincent, Lars Viktrup, Rebecca L. Robinson   +7 more
wiley   +1 more source

Intravesical Electromotive Botulinum Toxin in Women with Overactive Bladder – A Pilot Study

, 2017
Hjalmar Schiotz, Ha Mai, Renata Zabielska   +2 more
openalex   +1 more source

Gene arrangement in the upstream region of Clostridium botulinum type E and Clostridium butyricum BL6340 progenitor toxin genes is different from that of other types [PDF]

, 1998
Tohru Kubota
openalex   +1 more source